[VRTX] YoY Annual Result on 31-Dec-2014 [#FY]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
13-Feb-2015
Financial Year
2014
Quarter
31-Dec-2014 [#FY]
Profit Trend
YoY- -65.96%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Annual Result
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Revenue 2,488,652 1,702,177 1,032,336 580,415 1,211,975 1,527,042 1,410,626 9.91%
PBT -15,689 -67,366 -559,581 -734,875 -976,117 -12,381 60,445 -
Tax -107,324 16,665 30,381 6,958 -288,567 38,754 19,266 -
NP 263,484 -112,052 -558,115 -738,555 -445,028 -107,032 29,574 43.93%
Tax Rate - - - - - - -31.87% -
Total Cost 2,225,168 1,814,229 1,590,451 1,318,970 1,657,003 1,634,074 1,381,052 8.26%
Ratio Analysis
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
NP Margin 10.59 -6.58 -54.06 -127.25 -36.72 -7.01 2.10 30.91%
Per Share
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
EPS 1.06 -0.46 -2.32 -3.14 -1.98 -0.50 0.14 40.08%
EPS Diluted 1.04 -0.46 -2.31 -3.14 -1.98 -0.50 0.14 39.64%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.